• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/29

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

29 Cards in this Set

  • Front
  • Back
Definition of thrombocytopenia
Defined as 100,000 or less. Bleeding substantially increased at 20,000 or less.
Oprelvekin (interleukin-11)
approved for prevention of severe thrombocytopenia in patients undergoing chemo for non-myeloid malignancies
Dexrazoxane use in oncology patients
intracellular chelating agent and helps reduce damange from free radicals in daunorubicin, doxorubicin, idarubicin, and epirubicin and anthracenedione
Dexrazoxone cannot be used in what type of cancer
EARLY breat Cancer *curable*
Dexrazoxane can also be used in what setting?
Metastatic breast CA who have received doxorubicin 300 mg/m2 or more and want to continue receiving benefit from doxorubicin.
What is the antidote for extravasation of doxorubicin?
Dexrazoxazone
What medication prevents nephrotoxicity from cisplatin (side effects include hypotension, n/v, etc...)
Amifostine
What drug is used to prevent hemorrhagic cystitis from ifosfamide and in cyclophosphamide 1500 mg/m2 or greater?
Mesna (sodium-2-mercaptoethane sulfonate).
Prevents Acrolein which is a metabolite of ifosfamide and cyclophosphamide that damages the kidneys
Mesna must be present in the bladder when arolein is presented in bladder.
What types of cancer cause hypercalcemia (oncology emergency)?
Lung, breast, multiple myeloma, head and neck, renal cell, Non-Hodgkins lymphoma
What medications exacerbate hypercalcemia in oncology emergency?
hormonal tx, thiazide diuretics
What is the formula for corrected calcium?
[(4-plasma albumin) x 0.8 + serum Ca)]
What is the treatment for mild hypercalcemia (corrected Ca < 12 mg/dL)
NS hydration
What is the treatment for moderate hypercalcemia (12-14)
NS hydration
What is the treatment for severe hypercalcemia (>14)
Hydration 3-6 L in 24 hours
Loop diuretics (THIAZIDES CONTRAINDICATED b/c of renal tubular absorption)
Bisphosphonates
Calcitonin
Steroids
Phosphates
Dialysis if with renal failure
Tumor Lysis Syndrome
cell death due to leukemia or lymphoma.
causes hyperuricemia, hyperkalemia, hyperphosphatemia, and secondary hypocalcemia
uric acid can ppt renal failure
Tumor Lysis Syndrome treatment
hydration and allopurinol
rasburicase ($$)
What is used with MTX as a rescue med?
Leucovorin for doses greater than 100mg/m2.
In general MTX doses greater than 500 mg/m2 must have leucovorin rescue
Factors increasing MTX toxicity
renal dysfunction, third-space fluid, other meds that decrease MTX elimination (penicillin, NSAIDs, PPIs)
Leucovorin final result goal?
Continue until MTX falls to less than 0.05-0.1 mM.
Why do we use Leucovorin plus 5-FU
Leucovorin plus 5-FU enhances 5-FU
Which chemotherapy angents cause extravasation injuries
doxorubicin, daunorubicin, Epirubicin, mechlorethamine, Mitomycin, Vincristine, Vinblastine, Vinorelbine, Streptozocin, (w/ or without Oxaliplatin, with or without paclitaxel)

Most damaging -- Anthracyclines
Vincristine is fatal if given what route?
Intrathecal
Management of doxorubicin, daunorubicin, and epirubicin extravasation?
Cold and dexrazoxane
Management of extravasation for vincristine, vinblastine, or vinorelbine
HEAT
What is the management of extravastation of mechlorethamine?
sodium thiosulfate
What chemotherapy causes diarrhea and is managed with loperamide
Irinotecan
What medication is used to prevent the cholinergic activity irinotecan causing diarrhea?
Atropine
Which chemotherapy agents are renally adjusted
MTX, carboplatin, cisplatin, etoposide, bleomycin, topotecan, lienalidomide
Which chemotherapy agents are hepatically adjusted
doxorubicin, daunorubicin, vincristine, vinblastine, docetaxel, paclitaxel, sorafenib, and pazopanib